Skip to main content
SpringerLink
Log in

S3-Leitlinie „Supportive Therapie bei onkologischen PatientInnen“

Tumortherapie-induzierte Diarrhö

  • Fortbildung
  • Published:
Im Focus Onkologie Aims and scope

Tumortherapie-induzierte Diarrhö ist eine belastende und auch potenziell bedrohliche Nebenwirkung — gerade bei älteren oder untergewichtigen Patienten. Leichtere Verläufe lassen sich ambulant meist gut bewältigen, bei schwereren Verläufen ist aber oft eine stationäre Einweisung vonnöten. Wichtig ist es, die Patienten über das Risiko einer Diarrhö und gegebenenfalls erforderliche Reaktionen auf diese frühzeitig aufzuklären.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Literatur

  1. S3-Leitlinie Supportive Therapie bei onkologischen PatientInnen. Langversion 1.0 — November 2016. AWMF-Registernummer: 032/054OL.

  2. Andreyev J et al. Guidance on the management of diarrhoea during cancer chemotherapy. Lancet Oncol. 2014;15(10):e447–60.

    Article  PubMed  Google Scholar 

  3. Pessi MA et al. Targeted therapy-induced diarrhea: A review of the literature. Crit Rev Oncol Hematol. 2014;90(2):165–79.

    Article  CAS  PubMed  Google Scholar 

  4. Mego M et al. Prevention of irinotecan induced diarrhea by probiotics: A randomized double blind, placebo controlled pilot study. Complement Ther Med. 2015;23(3):356–62.

    Article  PubMed  Google Scholar 

  5. Wang YH et al. The efficacy and safety of probiotics for prevention of chemoradiotherapy-induced diarrhea in people with abdominal and pelvic cancer: a systematic review and meta-analysis. Eur J Clin Nutr. 2016;70(11):1246–1253.

    Article  PubMed  Google Scholar 

  6. Hagel S et al. [S2k-guideline gastrointestinal infectious diseases and Whipple’s disease]. Z Gastroenterol. 2015;53(5):418–59.

    Article  CAS  PubMed  Google Scholar 

  7. Vehreschild MJ et al. Diagnosis and management of gastrointestinal complications in adult cancer patients: evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Oncol. 2013;24(5):1189–202.

    Article  CAS  PubMed  Google Scholar 

  8. Benson AB 3rd et al. Recommended guidelines for the treatment of cancer treatment-induced diarrhea. J Clin Oncol. 2004;22(14):2918–26.

    Article  CAS  PubMed  Google Scholar 

  9. Kiliç D et al. Double-blinded, randomized, placebo-controlled study to evaluate the effectiveness of sulphasalazine in preventing acute gastrointestinal complications due to radiotherapy. Radiother Oncol. 2000;57(2):125–9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universitätsklinikum Carl Gustav Carus, PalliativCentrum & Medizinische Klinik I, Fetscherstrasse 74, 01307, Dresden, Deutschland

    Ulrich Schuler

  2. http://www.springermedizin.de

    Ulrich Wedding

Authors
  1. Ulrich Schuler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ulrich Wedding
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ulrich Schuler.

Additional information

Für die Arbeitsgemeinschaft Supportive Maßnahmen in er Onkologie, Rehabilitation und Sozialmedizin der Deutschen Krebsgesellschaft (ASORS). ASORS im Internet: www.asors.de

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schuler, U., Wedding, U. Tumortherapie-induzierte Diarrhö. Im Focus Onkologie 20, 42–45 (2017). https://doi.org/10.1007/s15015-017-3185-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15015-017-3185-2

Search

Navigation